인증 보도자료
-
- Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States
- Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“...
- 07월 01일 14:15
-
- FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
- Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch pro...
- 07월 01일 10:34
-
- DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-...
- 06월 29일 09:34
